27.38
Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten
After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Rigel (RIGL) - Yahoo Finance
Is Rigel Pharmaceuticals Inc. stock a contrarian buyTrade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com
Can Rigel Pharmaceuticals Inc. (RI2) stock double in coming years2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com
Rigel Pharmaceuticals Inc. stock volume spike explainedAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
Can Rigel Pharmaceuticals Inc. stock deliver strong Q4 earningsLong Setup & Daily Volume Surge Trade Alerts - newser.com
Volume spikes in Rigel Pharmaceuticals Inc. stock – what they meanTrade Ideas & Weekly High Momentum Picks - newser.com
Is this a good reentry point in Rigel Pharmaceuticals Inc.Market Risk Summary & Daily Entry Point Trade Alerts - newser.com
Momentum divergence signals in Rigel Pharmaceuticals Inc. chartBreakout Watch & Risk Adjusted Swing Trade Ideas - newser.com
What the charts say about Rigel Pharmaceuticals Inc. todayWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Why Rigel Pharmaceuticals Inc. stock could see breakout soonRisk Management & Daily Profit Focused Screening - newser.com
Is Rigel Pharmaceuticals Inc. stock recession proofWatch List & Weekly Breakout Stock Alerts - newser.com
How Rigel Pharmaceuticals’ R289 Trial Progress and FDA Designations Will Impact RIGL Investors - Yahoo Finance
Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Key Clinical Milestone for R289 - simplywall.st
Did Rigel's (RIGL) R289 Phase 1b Expansion Just Shift the Company's Pipeline Prospects? - simplywall.st
Is Rigel Pharmaceuticals Inc. stock reversal real or fakeMarket Trend Report & Safe Capital Growth Tips - newser.com
Rigel Pharmaceuticals (NASDAQ:RIGL) Receives "Hold (C+)" Rating from Weiss Ratings - MarketBeat
Rigel Pharmaceuticals stock advances as first patient enrolled in R289 study expansion - Investing.com
Multi factor analysis applied to Rigel Pharmaceuticals Inc.2025 Volume Leaders & Reliable Entry Point Alerts - newser.com
Published on: 2025-10-09 05:05:12 - newser.com
HC Wainwright & Co. Reiterates Rigel Pharmaceuticals (RIGL) Buy Recommendation - Nasdaq
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 4%What's Next? - MarketBeat
Rigel Pharmaceuticals (RIGL) Rating Reiterated as 'Buy' by HC Wa - GuruFocus
Rigel Pharmaceuticals' (RIGL) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Rigel Pharmaceuticals, Inc. Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS - MarketScreener
Rigel Pharmaceuticals (RIGL) Advances Phase 1b Study with New Pa - GuruFocus
Rigel announces first patient enrolled in dose expansion phase of 1b study of R289 in patients with lower-risk MDS - MarketScreener
Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded to "Hold" Rating by Zacks Research - MarketBeat
First patient enrolled: Rigel advances R289 Phase 1b dose expansion, 500 mg qd/bid, up to 40 pts for RP2D - Stock Titan
Does Rigel Pharmaceuticals Inc. qualify in momentum factor screening2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock profit from fiscal stimulusWeekly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Analyzing Rigel Pharmaceuticals Inc. with multi timeframe chartsWeekly Trend Recap & Free Technical Pattern Based Buy Signals - newser.com
Applying Elliott Wave Theory to Rigel Pharmaceuticals Inc.Fed Meeting & Proven Capital Preservation Methods - newser.com
Using portfolio simulators with Rigel Pharmaceuticals Inc. included2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Eastern Progress
Immune Thrombocytopenic Purpura (ITP) Pipeline 2025: Pioneering Clinical Developments by 30+ Global Leaders – DelveInsight | Featuring Sanofi, Takeda, Rigel Pharmaceuticals, Bristol-Myers Squibb - Barchart.com
Rigel Pharmaceuticals announces inducement grants - MarketScreener
A Deep Dive Into Rigel Pharmaceuticals (RIGL) Valuation After Voya Investment Management Expands Stake - simplywall.st
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
What analysts say about Rigel Pharmaceuticals Inc RI2 stockStock Buyback Updates & Free Rapid Wealth Multiplication - earlytimes.in
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):